Japan: PHC Holdings completes pathology business acquisition

PHC Holdings (PHCHD), a healthcare holding company based in Tokyo, has completed the acquisition of the anatomical pathology business of Thermo Fisher Scientific, the world’s largest maker of scientific instruments, for US$1.14 billion. The acquired anatomical pathology business will operate as a new stand-alone company named Epredia that will continue to serve as a global…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »